| Funding Opportunity |
Impacts of climate change across the cancer control continuum (R21 Clinical Trial Optional) Apply for PAR 25 152
Funding Number: PAR 25 152
Agency: National Institutes of Health
Funding Amount: Case Dependent |
NCI National Clinical Trials Network - Network Lead Academic Participating Sites (UG1 Clinical Trial Not Allowed) Apply for RFA CA 24 033
Funding Number: RFA CA 24 033
Agency: National Institutes of Health
Funding Amount: $1,700,000 |
Research on Informal and Formal Caregiving for Alzheimer's Disease (R21) Apply for PAR 15 351
Funding Number: PAR 15 351
Agency: National Institutes of Health
Funding Amount: $200,000 |
Chemical Probes and Drugs for Modulating HIV Transcription in the Context of Substance Use Disorders (R01 Clinical Trial Not Allowed) Apply for RFA DA 25 007
Funding Number: RFA DA 25 007
Agency: National Institutes of Health
Funding Amount: $400,000 |
Limited Competition: Cooperative Human Tissue Network (CHTN; UM1 Clinical Trial Not Allowed) Apply for RFA CA 23 024
Funding Number: RFA CA 23 024
Agency: National Institutes of Health
Funding Amount: $800,000 |
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) Apply for PAR 23 157
Funding Number: PAR 23 157
Agency: National Institutes of Health
Funding Amount: Case Dependent |
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) Apply for RFA CA 22 004
Funding Number: RFA CA 22 004
Agency: National Institutes of Health
Funding Amount: $300,000 |
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) Apply for PAR 21 341
Funding Number: PAR 21 341
Agency: National Institutes of Health
Funding Amount: Case Dependent |
Leveraging Artificial Intelligence (AI) tools for Substance Use Disorders (SUD) drug discovery and development (R41/R42 - Clinical Trial Not Allowed) Apply for RFA DA 22 021
Funding Number: RFA DA 22 021
Agency: National Institutes of Health
Funding Amount: Case Dependent |
HEAL Initiative: Optimizing Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional) Apply for RFA MH 21 145
Funding Number: RFA MH 21 145
Agency: National Institutes of Health
Funding Amount: $2,000,000 |
Strengthening HIV Prevention Efforts for Women in the Southern U.S. (R01 Clinical Trial Optional) Apply for RFA MH 21 151
Funding Number: RFA MH 21 151
Agency: National Institutes of Health
Funding Amount: Case Dependent |
Modeling HIV Neuropathology Using Microglia from Human iPSC and Cerebral Organoids (R01 Clinical Trial Not Allowed) Apply for RFA DA 20 023
Funding Number: RFA DA 20 023
Agency: National Institutes of Health
Funding Amount: $500,000 |
Exploiting Omics Assays to Investigate Molecular Regulation of Persistent HIV in Individuals with Substance Use Disorder (R61/R33 Clinical Trial Optional) Apply for RFA DA 19 003
Funding Number: RFA DA 19 003
Agency: National Institutes of Health
Funding Amount: $450,000 |
mHealth Tools for Individuals with Chronic Conditions to Promote Effective Patient-Provider Communication, Adherence to Treatment and Self-Management (R01 Clinical Trial Optional) Apply for PA 18 386
Funding Number: PA 18 386
Agency: National Institutes of Health
Funding Amount: Case Dependent |
Improving Quality of Care and Quality of Life for Persons with Alzheimers Disease and Related Dementias at the End of Life (R01 Clinical Trial Optional) Apply for PAS 18 030
Funding Number: PAS 18 030
Agency: National Institutes of Health
Funding Amount: Case Dependent |
Clinical Research Education and Career Development (CRECD) Program (R25) Apply for PAR 16 350
Funding Number: PAR 16 350
Agency: National Institutes of Health
Funding Amount: $500,000 |
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 - Clinical Trial Not Allowed) Apply for RFA CA 18 005
Funding Number: RFA CA 18 005
Agency: Department of Health and Human Services, National Institutes of Health
Funding Amount: $300,000 |
